作为肺癌微环境中的潜在生物标志物和免疫检查点信号调节器的外体纳米纤维:最近的进展和新兴概念
Naushad Ahmad Khan1,2, Mohammad Asim3, Kabir H Biswas4
1Department of Surgery, Trauma and Vascular Surgery Clinical Research, Hamad General Hospital, 3050, Doha, Qatar. nkhan13@hamad.qa.
Journal of experimental & clinical cancer research : CR
|August 28, 2023
概括
瘤衍生的外体细胞 (TEXs) 驱动肺癌的进展和免疫抑制. 了解TEX提供了新的生物标志物用于诊断,预后,并改进了针对肺癌的免疫治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 肺癌是全球癌症死亡的主要原因,存活率很低.
- 瘤衍生的外生体 (TEXs) 是介导细胞间通信的囊泡,反映了瘤的复杂性.
- TEXs影响瘤的微环境,影响免疫反应和癌症的进展.
研究的目的:
- 审查TEX在肺癌进展中的多方面的作用.
- 探索TEXs在肺免疫瘤学的临床意义.
- 突出TEX作为潜在的生物标志物和治疗点.
主要方法:
- 关于肺癌,外体细胞和免疫疗法研究的文献综述.
- 对TEXs分子组成和功能的分析.
- 对TEXs对免疫调节和癌症特征的影响的评估.
主要成果:
- TEXs促进肺癌转移,上皮细胞-介质细胞过渡,血管生成和免疫抑制.
- TEX 包含影响先天性和适应性免疫的因素.
- TEXs显示出作为预后和预测免疫治疗反应的生物标志物的潜力.
结论:
- TEXs是肺癌进展和免疫规避的关键驱动因素.
- TEXs代表了肺癌诊断,预后和监测的有希望的非侵入性生物标志物.
- 向TEX可能为改善肺癌治疗结果提供新的治疗策略.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K


